Asia Pacific Organoids Market Forecast to 2030 - Regional Analysis - by Organ Type, Application, Source, and Type

List of Tables

The Asia Pacific organoids market is expected to grow from US$ 341.24 million in 2022 to US$ 1,866.32 million by 2030. It is estimated to grow at a CAGR of 23.7% from 2022 to 2030.

Focus on Drug Discovery Activities Fuel the Asia Pacific Organoids Market

The increasing demand for new and advanced drugs is driving the overall pace of drug discovery and research. According to ClinicalTrials.gov, the total number of clinical trial studies in 2020 was estimated to be 356,282. A recent survey by the Hubrecht Institute states that organoids can potentially make expensive drugs more cost-effective by identifying patients who are not likely to benefit from the drug. An increasing number of clinical trials worldwide is expected to drive the demand for advanced medical technologies, including organoid models.

Further, organoids in drug discovery are not limited to just cancer, they are also used in other diseases, such as cystic fibrosis, polycystic kidney disease, microcephaly, and infectious diseases of the gut and airway. For instance, organoids can summarize the properties of an organ, such as organ structure and function. Also, organoids can restore a tissue or organ's original genetic and epigenetic state, making them suitable for gene editing. Various studies have shown positive results of combining CRISPR-Cas9 technology with organoids, which has expanded opportunities for breakthroughs in cystic fibrosis. According to a study 'CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank,' published in 2020, a biobank of cystic fibrosis intestinal organoids represented 664 patients, and ~20% of them were theoretically able to efficiently repair nonsense mutations in the cystic fibrosis transmembrane conductor receptor through adenine base editors. Despite a few achievements of gene-edited organoids in some animal models, their efficiency is significantly low, and the success rate is not high. Therefore, it is crucial to research and develop a process for gene-edited organoids' safety, long-term stability, and functionality.

Moreover, the COVID-19 pandemic triggered the need to develop human lung organoid models. For instance, MilliporeSigma developed a 3dGRO Human Lung Organoid Culture System that allows researchers to control, access, and reproduce organ tissue for culturing an organoid model of human lung epithelium that can aid in obtaining positive and successful results during their research. Thus, such innovations are expected to offer more significant growth opportunities for the market growth.

Asia Pacific Organoids Market Overview

The Asia Pacific organoids market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The market in the region is likely to continue to grow at the fastest rate during the forecast period owing to factors such as increasing incidences of cancer, growing demand for gene mutation and cancer research, government efforts to raise awareness related to human organoids, supportive regulations for the development and commercialization of advanced human organoids products, and increased funding for organoids research.

Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Organoids Market Segmentation

The Asia Pacific organoids market is segmented into organ type, type application, source, and country.

Based on organ type, the Asia Pacific organoids market is segmented into intestine, liver, stomach, pancreas, lung, brain, kidney, and others. The intestine segment held the largest share of the Asia Pacific organoids market in 2022.

Based on type, the Asia Pacific organoids market is segmented into instruments, consumables, and services. The consumables segment held the largest share of the Asia Pacific organoids market in 2022.

Based on application, the Asia Pacific organoids market is segmented into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, and others. The developmental biology disease segment held largest share of the Asia Pacific organoids market in 2022.

Based on source, the Asia Pacific organoids market is bifurcated into pluripotent stem cells and organ-specific adult stem cell. The pluripotent stem cells segment held a larger share of the Asia Pacific organoids market in 2022.

Based on country, the Asia Pacific organoids market is segmented into the Japan, China, Australia, India, South Korea, and the Rest of Asia Pacific. Japan dominated the Asia Pacific organoids market in 2022.

Cellesce, Corning Inc, InSphero, Merck KGaA, STEMCELL Technologies Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Asia Pacific organoids market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific organoids market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific organoids market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00018852

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Asia Pacific Key Insights
2.2 Asia Pacific Market Attractiveness

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Asia Pacific Organoids Market Landscape

4.1 Overview
4.2 Asia Pacific PEST Analysis

5. Asia Pacific Organoids Market - Key Industry Dynamics

5.1 Key Market Drivers:
- 5.1.1 Increasing Demand for Tumor Modeling and Biobanking
- 5.1.2 Growing Adoption of Personalized Drugs
- 5.1.3 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Key Market Restraints:
- 5.2.1 Issues Related to Incorporation of Organoids into Existing Workflows
- 5.2.2 Dearth of Skilled Professionals
5.3 Key Market Opportunities:
- 5.3.1 Focus on Drug Discovery Activities
5.4 Future Trends:
- 5.4.1 Combining Organoid with Organ-On-A-Chip
5.5 Impact Analysis:

6. Organoids Market - Asia Pacific Market Analysis

6.1 Asia Pacific Organoids Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Organoids Market - Revenue and Forecast to 2030 - by Type

7.1 Overview
7.2 Asia Pacific Organoids Market Revenue Share, by Organ Type 2022 & 2030 (%)
7.3 Stomach
- 7.3.1 Overview
- 7.3.2 Stomach: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Intestine
- 7.4.1 Overview
- 7.4.2 Intestine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Liver
- 7.5.1 Overview
- 7.5.2 Liver: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Pancreas
- 7.6.1 Overview
- 7.6.2 Pancreas: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Lung
- 7.7.1 Overview
- 7.7.2 Lung: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Brain
- 7.8.1 Overview
- 7.8.2 Brain: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.9 Kidney
- 7.9.1 Overview
- 7.9.2 Kidney: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
7.10 Others
- 7.10.1 Overview
- 7.10.2 Others: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Organoids Market - Revenue and Forecast to 2030 - by Application

8.1 Overview
8.2 Asia Pacific Organoids Market Revenue Share, by Application 2022 & 2030 (%)
8.3 Developmental Biology
- 8.3.1 Overview
- 8.3.2 Developmental Biology: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Disease Pathology of Infectious Disease
- 8.4.1 Overview
- 8.4.2 Disease Pathology of Infectious Disease: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Regenerative Medicine
- 8.5.1 Overview
- 8.5.2 Regenerative Medicine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Drug Toxicity and Efficacy Testing
- 8.6.1 Overview
- 8.6.2 Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Drug Discovery and Personalized Medicine
- 8.7.1 Overview
- 8.7.2 Drug Discovery and Personalized Medicine: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Organoids Market - Revenue and Forecast to 2030 - by Source

9.1 Overview
9.2 Asia Pacific Organoids Market Revenue Share, by Source 2022 & 2030 (%)
9.3 Pluripotent Stem Cells
- 9.3.1 Overview
- 9.3.2 Pluripotent Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Organ-specific Adult Stem Cells
- 9.4.1 Overview
- 9.4.2 Organ-specific Adult Stem Cells: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Organoids Market - Revenue and Forecast to 2030 - by Type

10.1 Overview
10.2 Asia Pacific Organoids Market Revenue Share, by Type 2022 & 2030 (%)
10.3 Instruments
- 10.3.1 Overview
- 10.3.2 Instruments: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Consumables
- 10.4.1 Overview
- 10.4.2 Consumables: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Services
- 10.5.1 Overview
- 10.5.2 Services: Asia Pacific Organoids Market - Revenue and Forecast to 2030 (US$ Million)

11. Asia Pacific Organoids Market - Country Analysis

11.1 Asia Pacific Organoids Market, Revenue and Forecast to 2030
- 11.1.1 Overview
- 11.1.2 Asia Pacific Organoids Market by Country
  - 11.1.2.1 China
    - 11.1.2.1.1 Overview
    - 11.1.2.1.2 China Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.1.3 China Organoids Market, by Organ Type
    - 11.1.2.1.4 China Organoids Market, by Application
    - 11.1.2.1.5 China Organoids Market, by Source
    - 11.1.2.1.6 China Organoids Market, by Type
  - 11.1.2.2 Japan
    - 11.1.2.2.1 Overview
    - 11.1.2.2.2 Japan Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.2.3 Japan Organoids Market, by Organ Type
    - 11.1.2.2.4 Japan Organoids Market, by Application
    - 11.1.2.2.5 Japan Organoids Market, by Source
    - 11.1.2.2.6 Japan Organoids Market, by Type
  - 11.1.2.3 India
    - 11.1.2.3.1 Overview
    - 11.1.2.3.2 India Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.3.3 India Organoids Market, by Organ Type
    - 11.1.2.3.4 India Organoids Market, by Application
    - 11.1.2.3.5 India Organoids Market, by Source
    - 11.1.2.3.6 India Organoids Market, by Type
  - 11.1.2.4 Australia
    - 11.1.2.4.1 Overview
    - 11.1.2.4.2 Australia Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.4.3 Australia Organoids Market, by Organ Type
    - 11.1.2.4.4 Australia Organoids Market, by Application
    - 11.1.2.4.5 Australia Organoids Market, by Source
    - 11.1.2.4.6 Australia Organoids Market, by Type
  - 11.1.2.5 South Korea
    - 11.1.2.5.1 Overview
    - 11.1.2.5.2 South Korea Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.5.3 South Korea Organoids Market, by Organ Type
    - 11.1.2.5.4 South Korea Organoids Market, by Application
    - 11.1.2.5.5 South Korea Organoids Market, by Source
    - 11.1.2.5.6 South Korea Organoids Market, by Type
  - 11.1.2.6 Rest of Asia Pacific
    - 11.1.2.6.1 Overview
    - 11.1.2.6.2 Rest of Asia Pacific Organoids Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.2.6.3 Rest of Asia Pacific Organoids Market, by Organ Type
    - 11.1.2.6.4 Rest of Asia Pacific Organoids Market, by Application
    - 11.1.2.6.5 Rest of Asia Pacific Organoids Market, by Source
    - 11.1.2.6.6 Rest of Asia Pacific Organoids Market, by Type

12. Pre & Post COVID-19 Impact

12.1 Pre & Post COVID-19 Impact

13. Asia Pacific Organoids Market Industry Landscape

13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
- 13.3.1 Overview
13.4 Inorganic Developments
- 13.4.1 Overview

14. Asia Pacific Organoids Market, Key Company Profiles

14.1 STEMCELL Technologies Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Cellesce Ltd
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Corning Inc
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Merck KGaA
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 InSphero
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments

15. Appendix

15.1 About Us
15.2 Glossary of Terms